Navigation Links
ZyGEM and Advalytix Partner to Produce Innovative DNA Extraction Products
Date:10/16/2008

-New Collaboration Brings ZyGEM's Unique Temperature-Controlled DNA Extraction Technology to Advalytix Customers as Private-Label Kits-

SOLANA BEACH, Calif. and HAMILTON, New Zealand and MUNICH, Germany, Oct. 16 /PRNewswire/ -- ZyGEM Corp. Ltd. today announced that it has entered into an agreement with the Advalytix product team of Olympus Life Science Research Europa GmbH to produce a private-label line of DNA extraction products. The collaboration will combine ZyGEM's advanced enzymatic nucleic acid extraction technology and Advalytix's expertise in single-cell molecular tests for life science research and diagnostic applications.

ZyGEM's DNA extraction technology uses a proprietary thermophilic enzyme to extract DNA from samples using a single closed-tube system. ZyGEM's approach simplifies laboratory workflow, minimises error, reduces the risk of contamination and ensures sample integrity, while also reducing costs. The technology can be specifically formulated for use with a wide range of different sample types without the need for further purification. ZyGEM's technology has been validated for use in research, forensic, diagnostic, agriculture and animal health applications.

"ZyGEM's unique temperature-controlled DNA extraction technology provides important advantages that are especially relevant as demand for DNA analysis continues to increase, and we are delighted to partner with an innovative group such as Advalytix to make our technology available to more users," said Paul Kinnon, CEO of ZyGEM. "This new agreement for private-label DNA extraction products is the most recent in a series of ZyGEM collaborations with diverse partners to ensure wide availability of our versatile technology, and we look forward to a mutually productive relationship with Advalytix."

Advalytix will market private-label DNA extraction products based on ZyGEM's temperature-controlled extraction (TEC) technology. The kits are designed to work with
'/>"/>

SOURCE ZyGEM Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. ZyGEM Appoints Leading Biotechnology Expert to Head Clinical Advisory Board
2. ZyGEM and DIAGNOTEC Collaborate on Diagnostics for Detecting a Devastating Virus Attacking Salmon
3. ONCOSCIENCE AG, THE EUROPEAN PARTNER OF YM BIOSCIENCES, ANNOUNCES COMPLETION OF PATIENT ENROLLMENT IN PHASE III BRAIN CANCER TRIAL OF NIMOTUZUMAB
4. YM BIOSCIENCES, EUROPEAN PARTNER, ONCOSCIENCE AG, ANNOUNCES INITIATION OF ADVANCED NIMOTUZUMAB TRIALS IN ADULT GLIOMA AND PANCREATIC CANCER
5. Operon Biotechnologies and DNA2.0 Announce Co-Marketing and Technology Development Partnership
6. NuVasive to Present at Thomas Weisel Partners Healthcare Conference
7. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2007
8. GenVault Partnership with Genome Quebec Brings $3.3 Million Sale of Dynamic Archive Product
9. ADVENTRX Pharmaceuticals to Present at the 2007 Thomas Weisel Partners Healthcare Conference
10. Caliper Life Sciences Presentation at Thomas Weisel Partners Healthcare Conference to be Webcast
11. SuperGen to Present at Thomas Weisel Partners Healthcare Conference September 5th
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)SAN FRANCISCO, Dec. 3 VIA Pharmaceuticals, Inc. (Nasdaq: VIAP ), a biotechnology company focused on the development of compounds for the treatment of cardiovascular and metabolic disease, today anno
(Date:12/3/2009)NEW DELHI, India, Dec. 3 /PRNewswire-Asia/ -- Dr. Susan Jiang, M.D., Ph.D.,Chief Science Officer at Shenzhen Beike Biotechnology Co. Ltd.,( http://www.beikebiotech.com ), spoke at a conference on Hig
(Date:12/2/2009)NEW YORK, Dec. 2 Reportlinker.com announces that a new market research report is available in its catalogue: ,, Drug Discovery Technologies - A Global Update of Market Trends & Opportunities ,,
(Date:12/2/2009)LIBREVILLE, Gabon, December 2 , - "Bolstering Biodiversity in Africa: Everyone,s Problem and Heritage" , Coinciding with the International Year of Biodiversity, 2-3 June 2010 the,Gabonese Rep
Breaking Biology Technology:VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 2VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 3VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 4Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 2Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 2Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 4Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 5Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 6Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 7Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 8Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 9Libreville International Conference 2-3 June 2010 2
...innovation in adaptive and assistive technology, ...PRNewswire/ - Touch,Bionics, developer of the worl... announced that the i-LIMB Hand has won a 2008 da ...ociety., The da Vinci Awards recognize the most i...d assistive technology. The National Multiple,Scle...
...ence Therapeutics plc (AIM: SLN), a,leading Europe...hat the US,Patent and Trademark Office has indicat... 10/633,630, Silence,s core RNAi patent applicatio...er announcement once the,official information has ...http://www.silence-therapeutics.com ), Silence Th...
...y 30 DNA Heritage has recently,overcome patent cl...y,restricted the use of DNA testing and databases ...connect up through their DNA. The patent covers th... family connection. The UK,Intellectual Property O...tating that the relevant claims are all invalid., ...
Other Biology Technology:Touch Bionics a 2008 da Vinci Award winner 2Silence Therapeutics Patent Update 2Silence Therapeutics Patent Update 3DNA Heritage Success in Patent Battle Helps Keep Genealogy DNA Test Prices Low 2
(Date:12/3/2009)Spanish researchers have measured CO2 levels for the past three years in the troposphere (lower atmosphere) over a sparsely inhabited rural area near Valladolid. The results, which are the first of th
(Date:12/2/2009)PHILADELPHIA Less acculturated Latino men have a more difficult time quitting smoking than those who are more acculturated to U.S. culture, but acculturation has no affect on Latinas odds of quitting
(Date:12/2/2009)PHILADELPHIA Exposure to secondhand smoke for a prolonged period of time and in high quantity may increase the risk of breast cancer, even in women who never smoked cigarettes themselves. , "The qu
Breaking Biology News(10 mins):CO2 levels rising in troposphere over rural areas 2Acculturation affects smoking cessation success among Latinos 2Exposure to secondhand cigarette smoke over a lifetime increased breast cancer risk later in life 2Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 14956 1Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 14956 2Health Robotics Continues its Global Expansion With December 09 ASHPs Launch of Joint Venture in Canada 14954 1Health Robotics Continues its Global Expansion With December 09 ASHPs Launch of Joint Venture in Canada 14954 2Zimmer Holdings to Present at 21st Annual Piper Jaffray Health Care Conference 6502 1
...g from a blood disorder that prevents proper clott...ramatically improve their health. There are estima...n the U.S. diagnosed with chronic immune thrombocy...dramatically reduces the number of platelets in th...ly, life-threatening brain hemorrhages. , Promac...
...ay, 22 March aims to raise public awareness of the...r planet. In a densely populated world, droughts a.... , Helmholtz scientists in the research field Ea...ecisely these problems. In cooperation with partne...eams, they are looking at the issue from all angle...
...ave always been fascinated by bats, but the scope ...fly and their bizarre habit of sleeping upside dow...t their daytime perches. , A Brown University-led...g approaches of three species of bats two that li...y found was surprising: Not all bats land the same...
Other Biology News:Lancet study supports new, highly effective treatment for blood disorder 2Lancet study supports new, highly effective treatment for blood disorder 3Research to secure a safe water supply 2Research to secure a safe water supply 3Research to secure a safe water supply 4Brown-led team offers first look at how bats land 2Brown-led team offers first look at how bats land 3
... containing a clone of the human Topoisomerase II ... topological state of nucleic acids by passing an ...enerates a separate DNA helix (1,2) . As a result ...enzyme can relax negatively or positively supercoi...
...I catalyzes the template-directed polymerization o...DNA Polymerase I possesses a 3?5 exonuclease activ...rror rate during DNA replication, and also contain...zyme to replace nucleotides in the growing strand ...
...e Klenow Fragment is a genetically engineered Klen...vity has been removed, leaving only the 5 to 3 pol...ctivity makes Exo- Klenow Fragment the enzyme of c...s by the random primed method, and for DNA sequenc...
T7 RNA Polymerase from Invitrogen
Biology Products: